| review article | Q7318358 |
| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1016228805 |
| P356 | DOI | 10.1186/1750-1172-1-10 |
| P932 | PMC publication ID | 1475837 |
| P698 | PubMed publication ID | 16722529 |
| P5875 | ResearchGate publication ID | 7059366 |
| P50 | author | Alan T Nurden | Q88562454 |
| P2860 | cites work | Family screening for a Glanzmann's thrombasthenia mutation using PCR-SSCP. | Q45817673 |
| The effect of platelets on fibrin gel structure formed in the presence of recombinant factor VIIa in hemophilia plasma and in plasma from a patient with Glanzmann thrombasthenia | Q45880844 | ||
| Specific synergy of multiple substrate-receptor interactions in platelet thrombus formation under flow. | Q45967882 | ||
| Prophylactic and therapeutic recombinant factor VIIa administration to patients with Glanzmann's thrombasthenia: results of an international survey. | Q47287128 | ||
| Prenatal diagnosis of Glanzmann thrombasthenia using the polymorphic markers BRCA1 and THRA1 on chromosome 17. | Q47720581 | ||
| Triple heterozygosity in the integrin alphaIIb subunit in a patient with Glanzmann's thrombasthenia. | Q47730309 | ||
| The human integrin beta3 gene is 63 kb and contains a 5'-UTR sequence regulating expression. | Q48043111 | ||
| Rational use of the PFA-100 device for screening of platelet function disorders and von Willebrand disease. | Q52039815 | ||
| Presentation and pattern of symptoms in 382 patients with Glanzmann thrombasthenia in Iran | Q61040725 | ||
| CD40L stabilizes arterial thrombi by a β3 integrin–dependent mechanism | Q63354517 | ||
| Detection of the Glanzmann's thrombasthenia mutations in Arab and Iraqi-Jewish patients by polymerase chain reaction and restriction analysis of blood or urine samples | Q67866855 | ||
| Prenatal diagnosis of Glanzmann's thrombasthenia | Q69875023 | ||
| Complete correction of Glanzmann's thrombasthenia by allogeneic bone-marrow transplantation | Q69888542 | ||
| The formation of Ca++-dependent complexes of platelet membrane glycoproteins IIb and IIIa in solution as determined by crossed immunoelectrophoresis | Q70549345 | ||
| The molecular genetic basis of Glanzmann's thrombasthenia in a gypsy population in France: identification of a new mutation on the alpha IIb gene | Q71911678 | ||
| The use of recombinant factor VIIa in children with inherited platelet function disorders | Q73320925 | ||
| The role of platelets in venous thrombosis: a patient with Glanzmann's thrombasthenia and a factor V Leiden mutation suffering from deep venous thrombosis | Q73691007 | ||
| Upregulation of osteoclast alpha2beta1 integrin compensates for lack of alphavbeta3 vitronectin receptor in Iraqi-Jewish-type Glanzmann thrombasthenia | Q73903668 | ||
| Thrombocytoasthenia and thrombocytopathia-old names and new diseases | Q74242714 | ||
| Glanzmann's thrombasthenia: identification of 19 new mutations in 30 patients | Q74359721 | ||
| Analysis of the amino acid requirement for a normal alphaIIbbeta3 maturation at alphaIIbGlu324 commonly mutated in Glanzmann thrombasthenia | Q78321200 | ||
| Protein A Sepharose immunoadsorption can restore the efficacy of platelet concentrates in patients with Glanzmann's thrombasthenia and anti-glycoprotein IIb-IIIa antibodies | Q78630148 | ||
| Dissociation between fibrinogen and fibrin interaction with platelets in patients with different subtypes of Glanzmann's thrombasthenia: studies in an ex vivo perfusion chamber model | Q78630152 | ||
| The molecular genetics of Glanzmann's thrombasthenia | Q79774022 | ||
| Elevated Flk1 (vascular endothelial growth factor receptor 2) signaling mediates enhanced angiogenesis in beta3-integrin-deficient mice | Q81085089 | ||
| Mutations in GPIIIa molecule as a cause for Glanzmann thrombasthenia in Indian patients | Q81479252 | ||
| Integrins: versatility, modulation, and signaling in cell adhesion | Q27860844 | ||
| Ser-752-->Pro mutation in the cytoplasmic domain of integrin beta 3 subunit and defective activation of platelet integrin alpha IIb beta 3 (glycoprotein IIb-IIIa) in a variant of Glanzmann thrombasthenia | Q28118972 | ||
| Molecular basis of Glanzmann's Thrombasthenia and current strategies in treatment | Q28216926 | ||
| Integrins: dynamic scaffolds for adhesion and signaling in platelets | Q28267584 | ||
| Persistence of platelet thrombus formation in arterioles of mice lacking both von Willebrand factor and fibrinogen | Q28588951 | ||
| Human IgG monoclonal anti-alpha(IIb)beta(3)-binding fragments derived from immunized donors using phage display | Q30805062 | ||
| Specific roles for platelet surface glycoproteins in platelet function | Q33339641 | ||
| Acquired Glanzmann's thrombasthenia without thrombocytopenia: a severe acquired autoimmune bleeding disorder | Q33363083 | ||
| Autoimmune thrombocytopenic purpura (AITP) and acquired thrombasthenia due to autoantibodies to GP IIb-IIIa in a patient with an unusual platelet membrane glycoprotein composition | Q33501616 | ||
| Platelet glycoprotein IIb/IIIa inhibitors: basic and clinical aspects. | Q33790993 | ||
| Mice lacking beta3 integrins are osteosclerotic because of dysfunctional osteoclasts | Q33939357 | ||
| A new variant of Glanzmann's thrombasthenia (Strasbourg I). Platelets with functionally defective glycoprotein IIb-IIIa complexes and a glycoprotein IIIa 214Arg----214Trp mutation | Q34221553 | ||
| Platelet vitronectin receptor expression differentiates Iraqi-Jewish from Arab patients with Glanzmann thrombasthenia in Israel | Q34571418 | ||
| Structural basis for allostery in integrins and binding to fibrinogen-mimetic therapeutics | Q35213036 | ||
| Gene therapy for platelet disorders: studies with Glanzmann's thrombasthenia | Q35589483 | ||
| Folding of the N-terminal, ligand-binding region of integrin alpha-subunits into a beta-propeller domain | Q35899468 | ||
| Truncation of the cytoplasmic domain of beta3 in a variant form of Glanzmann thrombasthenia abrogates signaling through the integrin alpha(IIb)beta3 complex | Q37374506 | ||
| The molecular genetic basis of Glanzmann thrombasthenia in the Iraqi-Jewish and Arab populations in Israel | Q37478529 | ||
| Glanzmann's thrombasthenia: the spectrum of clinical disease | Q37909047 | ||
| A single amino acid substitution flanking the fourth calcium binding domain of alpha IIb prevents maturation of the alpha IIb beta 3 integrin complex | Q38311244 | ||
| A beta 3 integrin mutation abolishes ligand binding and alters divalent cation-dependent conformation | Q38339624 | ||
| Major mutations in calf-1 and calf-2 domains of glycoprotein IIb in patients with Glanzmann thrombasthenia enable GPIIb/IIIa complex formation, but impair its transport from the endoplasmic reticulum to the Golgi apparatus | Q40667595 | ||
| Two novel mutations in the alpha IIb calcium-binding domains identify hydrophobic regions essential for alpha IIbbeta 3 biogenesis | Q40691230 | ||
| Missense mutations in the beta(3) subunit have a different impact on the expression and function between alpha(IIb)beta(3) and alpha(v)beta(3). | Q40755458 | ||
| A point mutation in the cysteine-rich domain of glycoprotein (GP) IIIa results in the expression of a GPIIb-IIIa (alphaIIbbeta3) integrin receptor locked in a high-affinity state and a Glanzmann thrombasthenia-like phenotype | Q40776610 | ||
| Probing conformational changes in the I-like domain and the cysteine-rich repeat of human beta 3 integrins following disulfide bond disruption by cysteine mutations: identification of cysteine 598 involved in alphaIIbbeta3 activation | Q40785864 | ||
| R to Q amino acid substitution in the GFFKR sequence of the cytoplasmic domain of the integrin IIb subunit in a patient with a Glanzmann's thrombasthenia-like syndrome | Q40991444 | ||
| Patients with Glanzmann thrombasthenia lacking platelet glycoprotein alpha(IIb)beta(3) (GPIIb/IIIa) and alpha(v)beta(3) receptors are not protected from atherosclerosis | Q43904601 | ||
| Recombinant factor VIIa enhances deposition of platelets with congenital or acquired alpha IIb beta 3 deficiency to endothelial cell matrix and collagen under conditions of flow via tissue factor-independent thrombin generation | Q44201546 | ||
| A naturally occurring Tyr143His alpha IIb mutation abolishes alpha IIb beta 3 function for soluble ligands but retains its ability for mediating cell adhesion and clot retraction: comparison with other mutations causing ligand-binding defects | Q44265494 | ||
| Dynamics of GPIIb/IIIa-mediated platelet-platelet interactions in platelet adhesion/thrombus formation on collagen in vitro as revealed by videomicroscopy | Q44279137 | ||
| An association of candidate gene haplotypes and bleeding severity in von Willebrand disease (VWD) type 1 pedigrees | Q44958587 | ||
| P275 | copyright license | Creative Commons Attribution 2.0 Generic | Q19125117 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Glanzmann's thrombasthenia | Q1529258 |
| P5008 | on focus list of Wikimedia project | ScienceSource | Q55439927 |
| P304 | page(s) | 10 | |
| P577 | publication date | 2006-04-06 | |
| P1433 | published in | Orphanet Journal of Rare Diseases | Q15756117 |
| P1476 | title | Glanzmann thrombasthenia | |
| P478 | volume | 1 |
| Q39976534 | A Toll-like receptor 2-integrin beta3 complex senses bacterial lipopeptides via vitronectin. |
| Q41144341 | A dual role for integrin-linked kinase in platelets: regulating integrin function and alpha-granule secretion |
| Q39434031 | A mutation in the β3 cytoplasmic tail causes variant Glanzmann thrombasthenia by abrogating transition of αIIb β3 to an active state |
| Q46804451 | A new case of acquired Glanzmann's thrombasthenia: diagnostic value of flow cytometry |
| Q44187162 | A rare case of bleeding disorder: Glanzmann's thrombasthenia |
| Q64227043 | Abdominal Surgical Emergencies in Patients with Hematological Disorders: An Exacting Experience for Surgeons |
| Q82212913 | Acute Epidural Hematoma in a Patient With Glanzmann's Thrombasthenia -Case Report- |
| Q37903933 | Advances in our understanding of the molecular basis of disorders of platelet function |
| Q39939850 | AlphaIIbG236E causes Glanzmann thrombasthenia by impairing association with beta3. |
| Q38006908 | Atomic force microscopy-based force spectroscopy--biological and biomedical applications |
| Q37740966 | Autosomal recessive inherited bleeding disorders in Pakistan: a cross-sectional study from selected regions |
| Q37294541 | Biomechanics of haemostasis and thrombosis in health and disease: from the macro- to molecular scale |
| Q47256063 | Cartilage acidic protein 1, a new member of the beta-propeller protein family with amyloid propensity |
| Q40238642 | Clinical Management of Glanzmann's Thrombasthenia: A Case Report |
| Q88418012 | Clinical and molecular insights into Glanzmann's thrombasthenia in China |
| Q42007238 | Clinical utility gene card for: Glanzmann thrombasthenia |
| Q34988402 | Comparison of platelet aggregation using light transmission and multiple electrode aggregometry in Glanzmann thrombasthenia |
| Q35013677 | Delineating the roles of the GPIIb/IIIa and GP-Ib-IX-V platelet receptors in mediating platelet adhesion to adsorbed fibrinogen and albumin. |
| Q41926876 | Diagnosis and Management of Inherited Platelet Disorders |
| Q33383957 | Dominant inheritance of a novel integrin beta3 mutation associated with a hereditary macrothrombocytopenia and platelet dysfunction in two Italian families |
| Q39181193 | Epistaxis as a Common Presenting Symptom of Glanzmann's Thrombasthenia, a Rare Qualitative Platelet Disorder: Illustrative Case Examples |
| Q51751582 | Excessive gingival bleeding in two patients with Glanzmann thrombasthenia. |
| Q35762807 | Extracellular matrix proteins in hemostasis and thrombosis |
| Q35230088 | Founder effect and estimation of the age of the French Gypsy mutation associated with Glanzmann thrombasthenia in Manouche families |
| Q30487560 | Functional genomics in zebrafish permits rapid characterization of novel platelet membrane proteins |
| Q54466253 | GDF-15 prevents platelet integrin activation and thrombus formation. |
| Q36532813 | Glanzmann thrombasthenia in Pakistan: molecular analysis and identification of novel mutations |
| Q33436665 | Glanzmann thrombasthenia in pregnancy: Optimising maternal and fetal outcomes |
| Q36250455 | Glanzmann thrombasthenia: about 11 cases |
| Q90089304 | Glanzmann thrombasthenia: genetic basis and clinical correlates |
| Q35106390 | Glanzmann's Thrombasthenia: A Rare Cause of Recurrent Profuse Epistaxis |
| Q97644677 | Glanzmann's Thrombasthenia: How Listening to the Patient Is Sometimes the Simple Key to Good Medicine! |
| Q34030931 | Glanzmann's thrombasthenia and pregnancy: report of a case and literature review |
| Q90655541 | Glanzmann's thrombasthenia with spontaneous upper gastrointestinal bleeding: a case report |
| Q34859954 | Glanzmann's thrombasthenia: an overview |
| Q37903946 | Gynecological and obstetrical manifestations of inherited bleeding disorders in women |
| Q40810885 | Hematuria: an uncommon presentation of Glanzmann's thrombasthenia-lessons learnt |
| Q38978645 | Identification of Clinicopathological Spectrum, Platelet Glycoprotein IIb/IIIa complex and Platelet Antibodies in Egyptian Children with Glanzmann's Thrombasthenia |
| Q33404901 | Identification of the integrin β3 L718P mutation in a pedigree with autosomal dominant thrombocytopenia with anisocytosis |
| Q33396427 | Inherited platelet disorders: a clinical approach to diagnosis and management |
| Q42139661 | Innovative use of recombinant activated factor VII during physical rehabilitation in an Italian child with Glanzmann's thromboasthenia |
| Q33952812 | L718P mutation in the membrane-proximal cytoplasmic tail of beta 3 promotes abnormal alpha IIb beta 3 clustering and lipid microdomain coalescence, and associates with a thrombasthenia-like phenotype |
| Q51746863 | Levonorgestrel-releasing intrauterine system for treatment of heavy menstrual bleeding in adolescents with Glanzmann's Thrombasthenia: illustrated case series. |
| Q55649547 | Mass Cytometry Reveals Distinct Platelet Subtypes in Healthy Subjects and Novel Alterations in Surface Glycoproteins in Glanzmann Thrombasthenia. |
| Q58569783 | Multidisciplinary Clinical Management of a Localized Aggressive Periodontitis diagnosed in a Child with Glanzmann's Thrombasthenia |
| Q33375248 | Murine models of platelet diseases |
| Q34120335 | Nasal packing with strips of cured pork as treatment for uncontrollable epistaxis in a patient with Glanzmann thrombasthenia |
| Q45876489 | Natural history of platelet antibody formation against αIIbβ3 in a French cohort of Glanzmann thrombasthenia patients |
| Q26766249 | New Insights Into the Treatment of Glanzmann Thrombasthenia |
| Q42365100 | Novel Mutations in the GPIIb and GPIIIa Genes in Glanzmann Thrombasthenia |
| Q53393838 | Novel and recurrent mutations of ITGA2B and ITGB3 genes in Korean patients with Glanzmann thrombasthenia. |
| Q38267207 | NovoSeven (recombinant factor VIIa) for the treatment of bleeding episodes and perioperative management in patients with Glanzmann's thrombasthenia |
| Q38258281 | Of von Willebrand factor and platelets |
| Q31059222 | Outside-in signalling generated by a constitutively activated integrin αIIbβ3 impairs proplatelet formation in human megakaryocytes |
| Q46306416 | Oxidative stress induced modulation of platelet integrin α2bβ3 expression and shedding may predict the risk of major bleeding in heart failure patients supported by continuous flow left ventricular assist devices |
| Q45919746 | Perioperative management of a patient with glanzmann's thrombasthenia for mitral valve repair under cardiopulmonary bypass. |
| Q44522050 | Platelet Integrins in Tumor Metastasis: Do They Represent a Therapeutic Target? |
| Q28077729 | Platelet Shape Changes and Cytoskeleton Dynamics as Novel Therapeutic Targets for Anti-Thrombotic Drugs |
| Q37903934 | Platelet adhesion and activation mechanisms in arterial thrombosis and ischaemic stroke |
| Q37807924 | Platelet receptor signaling in thrombus formation |
| Q37825820 | Recent advances in the understanding of the molecular mechanisms regulating platelet integrin αIIbβ3 activation |
| Q33553506 | Recognition and management of platelet-refractory bleeding in patients with Glanzmann's thrombasthenia and other severe platelet function disorders |
| Q33391528 | Specificities of neonatal hemostasis and implications in pathologic situations |
| Q90362013 | Strengths and Weaknesses of Light Transmission Aggregometry in Diagnosing Hereditary Platelet Function Disorders |
| Q36168430 | Successful Management of Acute Catastrophic Juvenile Vaginal Bleeding in Glanzmann's Thromboasthenia by Uterine Tamponade: A Case Report and Review of The Literature |
| Q38183284 | Talin and kindlin: the one-two punch in integrin activation |
| Q89660060 | The Extracellular Matrix: An Accomplice in Gastric Cancer Development and Progression |
| Q38257042 | Total Extraction as a Treatment for Anaemia in a Patient of Glanzmann's Thrombasthenia with Chronic Gingival Bleed: Case Report |
| Q37812365 | Treatment and outcomes for epistaxis in children with Glanzmann's thrombasthenia |
| Q36874262 | What's new in using platelet research? To unravel thrombopathies and other human disorders |
| Q64083979 | Molecular genetic diagnosis of Glanzmann syndrome in Iranian population; reporting novel and recurrent mutations | main subject | P921 |
Search more.